XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 9,808,330 $ 18,208,685
Short-term investments 52,931,831 55,931,821
Accounts receivable, net 18,281,133 22,155,301
Prepaid expenses and other 4,052,729 2,280,828
Total current assets 85,074,023 98,576,635
Property and equipment, net 140,968 137,448
Other assets    
Goodwill 22,673,820 22,673,820
Technology assets, net 8,366,375 7,702,895
Patent rights, net 1,831,839 1,940,178
Right of use assets, net 14,544 235,320
Other intangible assets, net 3,223,305 3,384,889
Total other assets 36,109,883 35,937,102
TOTAL ASSETS 121,324,874 134,651,185
Current liabilities    
Accounts payable – trade 817,779 1,549,979
Accrued expenses 1,503,477 2,601,246
Revenue share payable 2,722,127 3,990,440
Current portion of lease liabilities 14,545 89,902
Deferred revenue 451,787 164,309
Total current liabilities 5,509,715 8,395,876
Non-current liabilities    
Lease liabilities, net of current portion 144,532
Total liabilities 5,509,715 8,540,408
Commitments and contingencies (See note 10)
Stockholders’ equity    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, none issued and outstanding at June 30, 2023 or December 31, 2022
Common stock, $0.001 par value, 166,666,667 shares authorized, 18,376,771 and 18,288,571 shares issued at June 30, 2023 and December 31, 2022, respectively 18,377 18,289
Treasury stock, $0.001 par value, 1,741,397 and 1,214,398 shares held at June 30, 2023 and December 31, 2022, respectively (1,741) (1,214)
Additional paid-in-capital 173,049,784 172,785,800
Accumulated deficit (57,251,261) (46,692,098)
Total stockholders’ equity 115,815,159 126,110,777
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 121,324,874 $ 134,651,185